[1] |
Zhao Zhe, Mu Peijuan, Zhang Dong.
The efficacy of Endo combined with cisplatin in the treatment of lung cancer complicated with malignant pleural effusion:A meta-analysis
[J]. Clinical Focus, 2023, 38(5): 399-404.
|
[2] |
Guo Hao, Zhuang Huicui, Yang Limei, Ren Jing, Cui Dongsheng, Zhang Liran.
2019-2021 pathogen infection characteristics and drug resistance analysis on patients from Intensive Care Unit of the Hospital
[J]. Clinical Focus, 2022, 37(6): 519-524.
|
[3] |
Zhu Ying, Shu Qianqian, Chen Fuhui.
Clinical characteristics and drug resistance of community-acquired Acinetobacter baumannii pneumonia
[J]. Clinical Focus, 2022, 37(4): 315-319.
|
[4] |
Li Shufan, Wang Yuxiu, Jiang Zhenghua.
The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation
[J]. Clinical Focus, 2022, 37(11): 985-991.
|
[5] |
Peng Zhenli, Jiang Yao, Jia Lijuan, Wang Yanxin, Xue Weixiao, Shi Huiting.
Analysis of pathogenic bacteria resistance and prognosis of bloodstream infection
[J]. Clinical Focus, 2021, 36(8): 724-729.
|
[6] |
Shen Ziyuan, Kang Haiquan, Sang Wei, Yan Dongmei.
Analysis of bacterial distribution, resistance and risk factor of death of bacterial infection in leukemia patients
[J]. Clinical Focus, 2021, 36(12): 1092-1096.
|
[7] |
.
Metaanalysis of docetaxel, cisplatin and 5fluorouracil in treatment of advanced esophageal cancer
[J]. Clinical Focus, 2020, 35(5): 389-395.
|
[8] |
Li Xiaa, Ma Gaoxib, Hu Linglingc,Dong Fengmeib.
Distribution and drug resistance of Streptococcus pneumoniae infection in children
[J]. Clinical Focus, 2020, 35(2): 170-173.
|
[9] |
Yin Haiqing1a, Yao Baoguo2a, Chen Wanzhen1b, Su Li2b.
Risk factors and drug resistance of Carbapenemresistant Enterobacter in malignant tumor patients
[J]. Clinical Focus, 2020, 35(2): 166-169.
|
[10] |
Lu Yalei1, Song Lina2, Shan Yujie1, Zhang Xiaolin3a, Jia Jinhai3b.
Effect of endostatin combined with cisplatin on elderly cancer patients with malignant ascites
[J]. Clinical Focus, 2020, 35(2): 162-165.
|
[11] |
Shi Youshan, Chen Tianhao.
Pathogenic bacteria and etiological analysis of peritoneal dialysisassociated peritonitis in a single peritoneal dialysis center
[J]. Clinical Focus, 2020, 35(11): 1010-1014.
|
[12] |
Qiu Yi, Chen Lu, Qu Meidi, Zhang Min, Gu Hongliu, Sha Qi.
Effect of nutritional status on nausea and vomiting caused by chemotherapy in patients with lung cancer
[J]. Clinical Focus, 2019, 34(6): 549-552.
|
[13] |
Liu Qimeng, Ye Huan.
Risk factors for Carbapenemresistant and mortality in inpatients with pneumonia due to gramnegative bacteria
[J]. Clinical Focus, 2019, 34(4): 334-338.
|
[14] |
Zhang Pan, Xie Shoujun, Wen Hainan.
Distribution and drug resistance analysis of 1 113 strains of bloodstream infection
[J]. Clinical Focus, 2019, 34(2): 148-153.
|
[15] |
Fan Xin1, Chen Xinfei2, Xiao Meng2, Xu Yingchun2.
Research development on drug resistance and mechanisms of Clostridium difficile
[J]. Clinical Focus, 2018, 33(5): 377-380.
|